Tourmaline Bio, Inc. announced the promotion of Ryan Robinson, CPA, to Chief financial officer and Treasurer, effective June 25, 2024. Mr. Robinson most recently held the role of Vice President, Finance and Controller at Tourmaline, in addition to serving as Tourmaline?s interim chief financial officer and Treasurer since October 2023. Mr. Robinson has nearly 15 years of finance and operations experience within the biotechnology industry.

Before joining Tourmaline, Mr. Robinson served as Vice President of Finance and Treasurer at Korro Bio. Prior to Korro Bio, Mr. Robinson served as the Corporate Controller for Jounce Therapeutics. Mr. Robinson also worked at Merrimack Pharmaceuticals where he oversaw the financial and operational aspects of the commercial launch of ONIVYDE® for the treatment of metastatic pancreatic cancer.

Mr. Robinson began his career in the audit practice of Ernst & Young, where he served a variety of public and private life sciences companies at all stages of clinical development. Mr. Robinson earned a B.S. in Management and an M.S. in Accounting from Boston College, and he is licensed as a Certified Public Accountant.